PEX-FREE clinical trials

Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura

This study looks at a new way to treat a rare blood disorder called iTTP without daily plasma exchange. It combines other medicines and plasma infusions to see if it's safer and easier for patients, potentially reducing time in hospital and treatment complications.